MADISON – With funding from a National Institutes of Health 2021 High Risk, High Reward New Innovator Award, Shuang (George) Zhao, University of Wisconsin–Madison professor of human oncology, hopes to better understand why and how some cancers become resistant to treatment. Cancer is a leading cause...
“I know a lot of people I love would be here today, if their cancers had been detected early.” – Katie When Exact Sciences CEO Kevin Conroy started his job, his first stop was to Mayo Clinic for a talk with one of his biggest inspirations, the late...
Madison cancer diagnostics company Exact Sciences Corp. is working on a test that would screen for multiple types of cancer with a single blood draw. It’s aiming to help people catch early-stage cancer so it can be treated quickly. The test passed proof of concept in a...
Leo Cancer Care is an innovative start-up company who are set to change the face of Radiation Therapy forever. They recently completed their Series B fundraising activities, through parent company Asto CT Inc. alongside the team at Pureland Global Venture. The fundraise has seen investments...
More doesn’t necessarily mean better — including in cancer treatment. University of Wisconsin–Madison and University of Pittsburgh School of Medicine scientists report today in the journal Science Translational Medicine that combining targeted radiopharmaceutical therapy with immunotherapy significantly boosts eradication of metastatic cancer in mice, even when...